Travere Therapeutics Inc (TVTX) Smart Money Holdings (13F, Q2 2026)

TVTX ranks #1960 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

TVTX is a top-conviction position for Kynam Capital Management, LP — at 6.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in TVTX belongs to Jupiter Topco LLC, but the position matters far more to Kynam Capital Management, LP, who has 6.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Kynam Capital Management, LP has added to its TVTX position for two straight quarters, increasing it by $93.8M to reach $113.6M today.

Deutsche Bank Ag\ has trimmed its TVTX position for two straight quarters, cutting it by $20.9M while still holding $12.8M.

TVTX is up 2.7% today, and institutions have been net buyers of $565.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

TVTX reported a net loss of $43.5M over the trailing twelve months.

• Not yet profitable — net loss of $43.5M over the trailing twelve months
• Revenue grew 77.1% year over year
• Net income improved year over year, from -$169.1M to -$43.5M
• Generated $37.8M in positive operating cash flow
• Current ratio of 2.74x — enough short-term assets to cover short-term liabilities
• Liabilities run 4.27x equity — a highly leveraged balance sheet worth noting